First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
13 févr. 2020 07h00 HE
|
Laboratoris Sanifit S.L.
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis ...
Sanifit named as one of 2019’s “Fierce 15” biotechnology companies by FierceBiotech
23 sept. 2019 09h00 HE
|
Laboratoris Sanifit S.L.
Sanifit named as one of 2019’s “Fierce 15” biotechnology companies by FierceBiotech Palma, Spain and San Diego, USA, 23 September 2019 – Sanifit, a clinical-stage biopharmaceutical company focused on...
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
26 juin 2019 07h00 HE
|
Laboratoris Sanifit S.L.
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise Proceeds to enable progression of orphan designated lead candidate SNF472 into pivotal phase 3...
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
26 juin 2019 01h00 HE
|
Laboratoris Sanifit S.L.
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise Proceeds to enable progression of orphan designated lead candidate SNF472 into pivotal phase 3...
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
26 juin 2019 01h00 HE
|
Laboratoris Sanifit S.L.
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise Proceeds to enable progression of orphan designated lead candidate SNF472 into pivotal phase 3...
Sanifitがスペインのバイオテクノロジー企業のプライベート資金調達最高額となる7220万ユーロ(8090万ドル)を調達
26 juin 2019 01h00 HE
|
Laboratoris Sanifit S.L.
Sanifitがスペインのバイオテクノロジー企業のプライベート資金調達最高額となる7220万ユーロ(8090万ドル)を調達 資金調達により、希少薬指定リード医薬品候補SNF472の開発を前進させ、カルシフィラキシーを治療するための極めて重要な第III相試験が進展 -スペインの投資家Caixa Capital Risc主導のラウンド ...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
23 oct. 2018 07h00 HE
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
23 oct. 2018 02h00 HE
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...